1.Beck-Sague, CM, Jarvis, WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993;167:1247–1251.
2.Fisher-Hoch, SP, Hutwagner, L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995;21:897–904.
3.Pittet, D, Wenzel, RP. Nosocomial bloodstream infections: secular trends in rate, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177–1184.
4.Trick, WE, Fridkin, SK, Edwards, JR, Hajjeh, RA, Gaynes, RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35:627–630.
5.Hajjeh, RA, Sofair, AN, Harrison, LH, et al. Fluconazole resistance among Candida bloodstream isolates: incidence and correlation with outcome from a population-based study. Presented at the 39th Annual Meeting of the Infectious Diseases Society of America; October 2528, 2001; San Francisco, CA.
6.Pfaller, MA, Jones, RN, Messer, SA, Edmond, MB, Wenzel, RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998;31:327–332.
7.Jarvis, WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526–1530.
8.Edmond, MB, Wallace, SE, McClish, DK, Pfaller, MA, Jones, RN, Wenzel, RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239–244.
9.Pinner, RW, Teutsch, SM, Simonsen, L, et al.Trends in infectious diseases mortality in the United States. JAMA 1996;275:189–193.
10.Pittet, D, Li, N, Woolson, RF, Wenzel, RP. Microbiologic factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997;24:1068–1078.
11.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
12.Wey, SB, Motomi, M, Pfaller, MA, Woolson, RF, Wenzel, RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645.
13.Rentz, AM, Halpern, MT, Bowden, R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998; 27:781–788.
14.Guglaudsson, O, Gillespie, S, Lee, K, et al.Attributable mortality of candidemia, revisited. Clin Infect Dis 2003;37:1172–1177.
15.Chime. ChimeData Program. Wallingford, CT: Chime, Connecticut Hospital Association.
16.Health Services Cost Review Commission. Health Services Cost Review. Baltimore: Department of Health and Mental Hygiene of the State of Maryland.
17.Pappas, PG, Rex, JH, Sobel, JD, et al.Guidelines from the Infectious Diseases Society of America: guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161–189.
18.Haddix, AC, Corso, PS, Gorsky, RD. Costs. In: Haddix, AC, Teutsch, SM, Corso, PS, eds. Prevention Effectiveness, ed. 2. New York: Oxford University Press; 2003:53–76.
19.Meitzer, MI. Introduction to health economics for physicians. Lancet 2001;358:993–998.
20. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 1999 rates. 63 Federal Register 41099 (1998).
21. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2000 rates. 64 Federal Register 41620 (1999).
22.Bureau of Labor Statistics. Consumer Price Index. Washington, DC: Bureau of Labor Statistics, U.S. Bureau of Labor Statistics.
23.Goff, DASierawski, SJ, Fass, RJ. Cost analysis of Candida infection among surgical intensive care unit patients. Clinical Drug Investigation 1996;12:176–180.
24.Wilson, LS, Reyes, CM, Stolpman, M, Speckman, J, Allen, K, Beney, J. The direct cost and incidence of systemic fungal infections. Value Health 2002;5:26–34.
25.Torf, K. Economic aspects of treatment for fungal infections in cancer patients. Eur J Clin Microbiol Infect Dis 1997;16:98–107.
26.Rosenthal, GE, Harper, DL, Quinn, LM, et al.Severity-adjusted mortality and length of stay in teaching and nonteaching hospitals: results of a regional study. JAMA 1997;278:485–490.
27.Young, DS, Sachais, BS, Jefferies, LC. The cost of disease. Clin Chem 2000; 46:955–966.
28.Diekema, DJ, Messer, SA, Brueggemann, AB, et al.Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002;40:1298–1302.
29.Kao, AS, Brandt, ME, Pruitt, WR, et al.The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999;29:1164–1170.